Mumbai: Doctors at Holy Family Hospital, Bandra, performed a rare combined surgical procedure on a 29-year-old woman to remove extensive blood clots and restore circulation to her legs and ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

BACKGROUND: Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic ...

The UK demonstrates significant growth potential in the Cardiovascular Devices Market, driven by advancements in healthcare infrastructure and rising prevalence of cardiovascular diseases.

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

The France Cardiovascular Devices Market is poised to experience substantial growth, anticipated to reach US$ 1.01 billion by 2026, expanding at a robust CAGR of 6.8% from 2020 to 2026. This ...

The following is a summary of "Transit time flow management as a management strategy in high-risk groups undergoing coronary ...

While a hefty £1000 fine awaits anyone who is found to be dishonest in declaring their condition, drivers may also face ...

Hemodynamic analysis based on computational fluid dynamics (CFD) modelling is expected to improve risk stratification for patients with aortic aneurysms and dissections. However, the parameter ...